查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595313

药品契约製造与研究服务市场：按服务、最终用户划分 - 全球预测 2025-2030 年

Pharmaceutical Contract Manufacturing & Research Services Market by Service (Manufacturing, Research), End-User (Big Pharma, Generic Pharmaceutical Companies, Small & Mid-Size Pharma) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，药品契约製造和研究服务市场价值为2111.4亿美元，预计到2024年将达到2255.2亿美元，复合年增长率为6.90%，到2030年将达到3368.7亿美元，预计将达到1000万美元。

药品契约製造和研究服务市场包括向製药公司提供药物开发、製造、研究和其他服务的第三方公司。透过外包关键职能，市场在帮助製药公司提高灵活性、降低成本和加快上市时间方面发挥关键作用。这些服务的需求源于与内部药物开发和製造相关的复杂性和高成本。应用包括配方开发、临床试验管理和商业製造，最终用户包括大型製药公司、生物技术公司和学名药製造商。

主要市场统计
基准年[2023] 2111.4亿美元
预测年份 [2024] 2255.2亿美元
预测年份 [2030] 3368.7亿美元
复合年增长率（%） 6.90%

关键的成长要素包括对生技药品的需求增加、对具有成本效益的药物生产的需求不断增长以及推动公司寻找专业供应商的严格监管要求。连续加工和自动化等製造流程的技术进步正在创造巨大的商机。研发投资的增加和学名药生产的扩张将进一步推动市场。然而，严格的监管合规、供应链中断以及契约製造製造商的高初始投资等挑战可能会阻碍成长。此外，对资料安全和智慧财产权的担忧也带来了重大风险。

个人化医疗、先进药物输送系统以及在研究服务中引入人工智慧和机器学习等创新领域提供了巨大的商机。企业应专注于发展生物製造平台，加强特色药物製造能力，以把握未来的成长机会。与科技公司合作利用数位转型可以进一步使您的服务产品脱颖而出。市场相关人员必须优先考虑建立强有力的法律规范和灵活的供应链以降低风险。总体而言，这个市场具有不断变化的需求和竞争格局，具有动态性，为创新和扩张提供了重要的机会，可以透过与最新的技术和监管趋势保持一致来抓住这些机会。

市场动态：快速发展的药品契约製造和研究服务市场的关键市场洞察

药品契约製造和研究服务市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • CDMO增加以及CDMO增加对先进製造技术的投资
    • 增加对药物开发/发现和先进製造技术的投资
    • 大型製药企业外包数量增加
  • 市场限制因素
    • 对委外研发机构的监管压力
  • 市场机会
    • 对专业测试服务的需求不断增长
    • 标靶治疗的细胞和基因疗法的需求不断增长
  • 市场挑战
    • 贸易政策因国家而异

波特五力策略工具引领药品契约製造与研究服务市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药品契约製造和研究服务市场的外部影响

外部宏观环境因素在塑造药品契约製造和研究服务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药品契约製造和研究服务市场的竞争状况

药品契约製造和研究服务市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵药品契约製造与研究服务市场供应商的绩效评估

FPNV 定位矩阵是评估药品契约製造和研究服务市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製药品契约製造和研究服务市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对药品契约製造和研究服务市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • CDMO数量增加以及CDMO加大对先进製造技术的投资
      • 增加对药物开发/发现和先进製造技术的投资
      • 大型药厂外包数量增加
    • 抑制因素
      • 对合约研究机构服务的监管压力
    • 机会
      • 对专业测试服务的需求不断增长
      • 对标靶治疗的细胞和基因治疗的需求不断增加
    • 任务
      • 各国贸易政策差异
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品契约製造与研究服务市场：依服务分类

  • 製造业
    • 先进的药物输送配方包装
    • 原料药/原料药
    • 最终剂量配方
      • 液体配方
      • 半固态製剂
      • 固态製剂
    • 包裹
  • 调查
    • 心臟病学
    • 发炎和免疫学
    • 神经科学
    • 肿瘤学
    • 疫苗

第七章 药品契约製造与研究服务市场：依最终用户分类

  • 大型製药公司
  • 学名药公司
  • 中小型製药企业

第八章美洲药品契约製造与研究服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太药品契约製造与研究服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的医药契约製造和研究服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie, Inc.
  • Aenova Holding GmbH
  • Baxter International Inc.
  • Boehringer Ingelheim GmbH
  • Catalent, Inc.
  • Famar Group
  • Grifols SA
  • IQVIA
  • Jubilant Life Sciences Limited
  • Lonza Group
  • Pfizer, Inc.
  • Pharmaceutical Product Development, LLC
  • Recipharm AB
  • Valeant Pharmaceuticals International Inc.
  • Vetter Pharma-Fertigung GmbH & Co. KG
Product Code: MRR-AD36CD898497

The Pharmaceutical Contract Manufacturing & Research Services Market was valued at USD 211.14 billion in 2023, expected to reach USD 225.52 billion in 2024, and is projected to grow at a CAGR of 6.90%, to USD 336.87 billion by 2030.

The Pharmaceutical Contract Manufacturing & Research Services market encompasses third-party companies providing services such as drug development, manufacturing, and research to pharmaceutical firms. This market plays a critical role by allowing pharmaceutical companies to outsource key functions, which can enhance flexibility, reduce costs, and accelerate time to market. The necessity of these services arises from the complexity and high costs associated with in-house drug development and manufacturing. Applications include formulation development, clinical trial management, and commercial production, catering to end-users such as large pharmaceutical firms, biotechnology companies, and generic drug manufacturers.

KEY MARKET STATISTICS
Base Year [2023] USD 211.14 billion
Estimated Year [2024] USD 225.52 billion
Forecast Year [2030] USD 336.87 billion
CAGR (%) 6.90%

Key growth factors include the increasing demand for biologics, the growing need for cost-efficient drug manufacturing, and stringent regulatory requirements pushing companies to seek expert providers. Technological advancements in manufacturing processes, such as continuous processing and automation, offer substantial opportunities. The rise in R&D investment and the expansion of generic drug production further propel the market. However, challenges such as stringent regulatory compliance, supply chain disruptions, and the high initial investment for contract manufacturers may hinder growth. Additionally, data security and intellectual property concerns pose significant risks.

Innovative areas such as personalized medicine, advanced drug delivery systems, and the implementation of AI and machine learning in research services present significant opportunities. Companies should focus on developing platforms for biomanufacturing and enhancing their capabilities in specialized drug production to capture future growth. Collaboration with tech firms to leverage digital transformation can further distinguish service offerings. Market players must prioritize building robust regulatory frameworks and agile supply chains to mitigate risks. Overall, this market bears a dynamic nature with evolving demands and a competitive landscape, offering vast opportunities for innovation and expansion that can be seized by aligning with the latest technological and regulatory trends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Contract Manufacturing & Research Services Market

The Pharmaceutical Contract Manufacturing & Research Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of CDMOs and rising investments in advanced manufacturing technologies by CDMOs
    • Rising investments in drug development & discovery and advanced manufacturing technologies
    • Growing outsourcing volume by big pharmaceutical companies
  • Market Restraints
    • Regulatory pressure on contract research organization services
  • Market Opportunities
    • Growing demand for specialized testing services
    • Growing demand for cell and gene therapies for targeted treatment
  • Market Challenges
    • Variable trade policies between countries

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Contract Manufacturing & Research Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Contract Manufacturing & Research Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Contract Manufacturing & Research Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Contract Manufacturing & Research Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Contract Manufacturing & Research Services Market

A detailed market share analysis in the Pharmaceutical Contract Manufacturing & Research Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Contract Manufacturing & Research Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Contract Manufacturing & Research Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Contract Manufacturing & Research Services Market

A strategic analysis of the Pharmaceutical Contract Manufacturing & Research Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Contract Manufacturing & Research Services Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Holding GmbH, Baxter International Inc., Boehringer Ingelheim GmbH, Catalent, Inc., Famar Group, Grifols S.A, IQVIA, Jubilant Life Sciences Limited, Lonza Group, Pfizer, Inc., Pharmaceutical Product Development, LLC, Recipharm AB, Valeant Pharmaceuticals International Inc., and Vetter Pharma-Fertigung GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Contract Manufacturing & Research Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Manufacturing and Research. The Manufacturing is further studied across Advanced Drug Delivery Formulations Packaging, API/Bulk Drugs, Finished Dose Formulations, and Packaging. The Finished Dose Formulations is further studied across Liquid Formulations, Semi-Solid Formulations, and Solid Formulations. The Research is further studied across Cardiology, Inflammation & Immunology, Neuroscience, Oncology, and Vaccines.
  • Based on End-User, market is studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-Size Pharma.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of CDMOs and rising investments in advanced manufacturing technologies by CDMOs
      • 5.1.1.2. Rising investments in drug development & discovery and advanced manufacturing technologies
      • 5.1.1.3. Growing outsourcing volume by big pharmaceutical companies
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory pressure on contract research organization services
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for specialized testing services
      • 5.1.3.2. Growing demand for cell and gene therapies for targeted treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Variable trade policies between countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Contract Manufacturing & Research Services Market, by Service

  • 6.1. Introduction
  • 6.2. Manufacturing
    • 6.2.1. Advanced Drug Delivery Formulations Packaging
    • 6.2.2. API/Bulk Drugs
    • 6.2.3. Finished Dose Formulations
      • 6.2.3.1. Liquid Formulations
      • 6.2.3.2. Semi-Solid Formulations
      • 6.2.3.3. Solid Formulations
    • 6.2.4. Packaging
  • 6.3. Research
    • 6.3.1. Cardiology
    • 6.3.2. Inflammation & Immunology
    • 6.3.3. Neuroscience
    • 6.3.4. Oncology
    • 6.3.5. Vaccines

7. Pharmaceutical Contract Manufacturing & Research Services Market, by End-User

  • 7.1. Introduction
  • 7.2. Big Pharma
  • 7.3. Generic Pharmaceutical Companies
  • 7.4. Small & Mid-Size Pharma

8. Americas Pharmaceutical Contract Manufacturing & Research Services Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Contract Manufacturing & Research Services Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing & Research Services Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie, Inc.
  • 2. Aenova Holding GmbH
  • 3. Baxter International Inc.
  • 4. Boehringer Ingelheim GmbH
  • 5. Catalent, Inc.
  • 6. Famar Group
  • 7. Grifols S.A
  • 8. IQVIA
  • 9. Jubilant Life Sciences Limited
  • 10. Lonza Group
  • 11. Pfizer, Inc.
  • 12. Pharmaceutical Product Development, LLC
  • 13. Recipharm AB
  • 14. Valeant Pharmaceuticals International Inc.
  • 15. Vetter Pharma-Fertigung GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS PACKAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PACKAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY INFLAMMATION & IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, FPNV POSITIONING MATRIX, 2023